(MRK) Merck - Performance -34.4% in 12m
MRK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
16.61%
#46 in Peer-Group
Rel. Strength
16.32%
#6366 in Stock-Universe
Total Return 12m
-34.41%
#138 in Peer-Group
Total Return 5y
33.81%
#42 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 11.8 |
| P/E Forward | 8.87 |
| High / Low | USD |
|---|---|
| 52 Week High | 129.91 USD |
| 52 Week Low | 73.47 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.71 |
| Buy/Sell Signal +-5 | -0.93 |
| Support / Resistance | Levels |
|---|---|
| Support | 81.4, 77.4 |
| Resistance | 99.1, 94.9 |
12m Total Return: MRK (-34.4%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: MRK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for MRK
| Total Return (including Dividends) | MRK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.24% | 4.35% | 1.11% |
| 3 Months | -13.80% | -6.89% | 5.58% |
| 12 Months | -34.41% | -5.08% | 10.51% |
| 5 Years | 33.81% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | MRK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 74.3% | 65.8% | 69.9% |
| 3 Months | -64.7% | -72% | 69.3% |
| 12 Months | -96.7% | -62.2% | 43.2% |
| 5 Years | 77.6% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #68 | 4.69% | 8.04% |
| 3 Month | #141 | -7.42% | -18.35% |
| 12 Month | #136 | -30.90% | -40.64% |
| 5 Years | #46 | -11.11% | -36.01% |
FAQs
Does Merck (MRK) outperform the market?
No,
over the last 12 months MRK made -34.41%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months MRK made -13.80%, while XLV made -6.89%.
Performance Comparison MRK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.5% | 8.1% | -16.6% | -45% |
| US NASDAQ 100 | QQQ | 3.7% | 7.8% | -15.9% | -44% |
| German DAX 40 | DAX | 5.7% | 10% | -33% | -64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.7% | 10.2% | -18.5% | -46% |
| Hongkong Hang Seng | HSI | 3% | 4.2% | -35.7% | -62% |
| India NIFTY 50 | INDA | 5.2% | 10.6% | -15.6% | -33% |
| Brasil Bovespa | EWZ | 1.1% | 8.8% | -36.8% | -44% |
MRK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.8% | 7.8% | -19.4% | -57% |
| Consumer Discretionary | XLY | 4% | 11% | -6.8% | -52% |
| Consumer Staples | XLP | 3.8% | 9.5% | -18.1% | -41% |
| Energy | XLE | -2.4% | 6.3% | -20.2% | -38% |
| Financial | XLF | 5% | 11.8% | -19.5% | -58% |
| Health Care | XLV | 1.5% | 4.9% | -16.2% | -29% |
| Industrial | XLI | 4.5% | 8.9% | -22.2% | -53% |
| Materials | XLB | 4.1% | 7.8% | -17.4% | -34% |
| Real Estate | XLRE | 2.9% | 8.3% | -17.6% | -48% |
| Technology | XLK | 3.2% | 7.2% | -17% | -39% |
| Utilities | XLU | 2.1% | 8.7% | -25% | -56% |
| Aerospace & Defense | XAR | 4.5% | 3.5% | -33.6% | -77% |
| Biotech | XBI | 3.8% | 1.5% | -5.9% | -27% |
| Homebuilder | XHB | 5.1% | 14.3% | -1.2% | -25% |
| Retail | XRT | 7.4% | 9.4% | -8.7% | -35% |
MRK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -8.3% | -9.45% | -26.5% | -38% |
| Natural Gas | UNG | 4.2% | 11.9% | -34.9% | -20% |
| Gold | GLD | -0.2% | 3.1% | -46.8% | -82% |
| Silver | SLV | 4.3% | -2.1% | -36.2% | -57% |
| Copper | CPER | 6% | 7.5% | -31.5% | -43% |
MRK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2% | 8.6% | -15.2% | -30% |
| iShares High Yield Corp. Bond | HYG | 3% | 8.7% | -20.3% | -44% |